Stefan
Raos,
General Manager, Canada
(Corporation)
Learn more...
Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.
Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.
Results below are sorted by posted date, beginning with the most recent.
-
Moderna Biopharma Canada Corporation
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Andrea Gilpin,
Chief of Staff
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health,
Economic Development
Communication date:
2025-02-27
Posted date:
2025-03-14
Communication number:
370107-633424
View monthly communication report
-
Moderna Biopharma Canada Corporation
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Ritu Banerjee,
Assistant Deputy Minister
| Director General's Office
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Science and Technology,
Research and Development,
Economic Development
Communication date:
2025-02-25
Posted date:
2025-03-14
Communication number:
370107-633423
View monthly communication report
-
Moderna Biopharma Canada Corporation
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Gérard Deltell,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Science and Technology,
Research and Development,
Economic Development
Communication date:
2025-02-24
Posted date:
2025-03-14
Communication number:
370107-633422
View monthly communication report
-
Moderna Biopharma Canada Corporation
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Pierre Paul-Hus,
Member of Parlliament
|
House of Commons
Subject Matter of the communication:
Health,
Science and Technology,
Research and Development,
Economic Development
Communication date:
2025-02-20
Posted date:
2025-03-14
Communication number:
370107-633421
View monthly communication report
-
Moderna Biopharma Canada Corporation
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Kelly Block,
Member Of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Science and Technology,
Research and Development,
Economic Development
Communication date:
2025-02-18
Posted date:
2025-03-14
Communication number:
370107-633416
View monthly communication report
